Marina Simian is the Co-founder and CEO of Oncoliq, where she spearheads the development of pioneering oncology solutions aimed at transforming cancer treatment. Her leadership and strategic vision are central to Oncoliq’s mission to advance personalized medicine and improve patient outcomes in oncology.
Prior to co-founding Oncoliq, Marina gained extensive experience in management and consulting roles, demonstrating her expertise in creating and scaling successful ventures. Her educational background and professional journey reflect a deep commitment to advancing healthcare and fostering innovation in the biotech industry.
Marina holds a Master of Business Administration (MBA) from INSEAD and a Bachelor’s degree in Business Administration from the University of Buenos Aires.